NEW YORK (GenomeWeb News) - BioMachines and the University of Massachusetts Medical School announced a partnership to create a new proteomic division at the company, BioMachines said today.
 
The new division will be named Applied Proteomics Services. According to BioMachines CEO Tom Larrichio, the company will provide protein analysis through a fee-for-service model.
 
Sunny Tam and Douglas Hinerfeld, researchers from the medical school's Proteomic Fractionation Group, will support the new division.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.